The content you’re trying to view is for members only. Please register in order to access this content.
News
- Kindred Biosciences Announces Positive Results from Pilot Field Efficacy Study of its IL-4/IL-13 SINK Molecule Being Developed for the Treatment of Atopic Dermatitis in DogsMarch 24, 2020 - 8:33 am
- Kindred Biosciences Announces Mirataz® (mirtazapine transdermal ointment) Transaction and Reports Fourth Quarter and Full Year 2019 Financial ResultsMarch 16, 2020 - 4:03 pm
- Kindred Biosciences to Announce Fourth Quarter and Year-End 2019 Financial ResultsMarch 3, 2020 - 4:04 pm
Events
- Event: Kindred Biosciences to Announce Fourth Quarter and Year-End 2019 Financial ResultsMarch 3, 2020 - 4:05 pm
- Event: Kindred Biosciences to Present at Bank of America Merrill Lynch Animal Health SummitFebruary 18, 2020 - 8:38 am
- Event: Kindred Biosciences to Present at Stifel Healthcare ConferenceNovember 14, 2019 - 4:11 pm
$3.91
-0.17 (-4.17%)
|
||||||||||||||||
KindredBio proudly supports
Rabies Free Africa

